Zobrazeno 1 - 10
of 114
pro vyhledávání: '"R R, Lawson"'
Publikováno v:
Research communications in chemical pathology and pharmacology. 77(2)
A series of imipramine analogs were tested for inhibition of [3H]-MK801 binding and for their ability to protect against NMDA-induced lethality in mice. The structure-activity relationship (SAR) for the inhibition of [3H]-MK801 binding found primary
N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs
Publikováno v:
Brain research. 448(1)
N-Methyl-D-aspartic acid (NMDA) produced a dose-related increase in lethality in mice, with 200 mg/kg (i.p.) effecting 100% lethality. Upon daily dosing, acutely sublethal doses of NMDA produced deaths. This NMDA-induced lethality was stereoselective
Autor:
Jardou M; INSERM, Univ. Limoges, Pharmacology & Transplantation, U1248, F-87000 Limoges, France., Lawson R; INSERM, Univ. Limoges, Pharmacology & Transplantation, U1248, F-87000 Limoges, France. Electronic address: roland.lawson@unilim.fr.
Publikováno v:
Medical hypotheses [Med Hypotheses] 2021 Sep; Vol. 154, pp. 110661. Date of Electronic Publication: 2021 Aug 05.
Autor:
Graham DJ; Department of Hand and Peripheral Nerve Surgery, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Sivakumar BS; Department of Hand and Peripheral Nerve Surgery, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Lawson R; Department of Hand and Peripheral Nerve Surgery, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Publikováno v:
Annals of the Royal College of Surgeons of England [Ann R Coll Surg Engl] 2020 Mar; Vol. 102 (3), pp. e70-e72. Date of Electronic Publication: 2019 Dec 20.
Autor:
Llanos-Paez CC; School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia c.llanospaez@uq.edu.au., Staatz CE; School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia., Lawson R; The Queensland Children's Hospital, Brisbane, QLD, Australia., Hennig S; School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Jan 27; Vol. 64 (2). Date of Electronic Publication: 2020 Jan 27 (Print Publication: 2020).
Autor:
Llanos-Paez CC; School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia c.llanospaez@uq.edu.au., Staatz CE; School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia., Lawson R; The Lady Cilento Children's Hospital, Brisbane, Queensland, Australia., Hennig S; School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Jul 25; Vol. 61 (8). Date of Electronic Publication: 2017 Jul 25 (Print Publication: 2017).
Autor:
Harnan SE; Health Economics and Decision Science, ScHARR, University of Sheffield, Sheffield, UK., Essat M; Health Economics and Decision Science, ScHARR, University of Sheffield, Sheffield, UK., Gomersall T; Health Economics and Decision Science, ScHARR, University of Sheffield, Sheffield, UK., Tappenden P; Health Economics and Decision Science, ScHARR, University of Sheffield, Sheffield, UK., Pavord I; Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Everard M; School of Paediatrics & Child Health, Princess Margaret Hospital, University of Western Australia, Crawley, WA, Australia., Lawson R; Department of Respiratory Medicine, Royal Hallamshire Hospital, Sheffield, UK.
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2017 Mar; Vol. 47 (3), pp. 410-429. Date of Electronic Publication: 2017 Feb 13.
Autor:
Arepyeva MA; Saint Petersburg State University, Kollontai St., Saint Petersburg, Russian Federation. Electronic address: arepeva.maria@gmail.com., Kolbin AS; Saint Petersburg State University, Kollontai St., Saint Petersburg, Russian Federation; First Pavlov State Medical University of Saint Petersburg, Saint Petersburg, Russian Federation., Sidorenko SV; Scientific Research Institute of Children's Infections, Saint Petersburg, Russian Federation., Lawson R; AstraZeneca, Gaithersburg, Maryland, USA., Kurylev AA; First Pavlov State Medical University of Saint Petersburg, Saint Petersburg, Russian Federation., Balykina YE; Saint Petersburg State University, Kollontai St., Saint Petersburg, Russian Federation., Mukhina NV; First Pavlov State Medical University of Saint Petersburg, Saint Petersburg, Russian Federation., Spiridonova AA; First Pavlov State Medical University of Saint Petersburg, Saint Petersburg, Russian Federation.
Publikováno v:
Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2017 Mar; Vol. 8, pp. 148-156. Date of Electronic Publication: 2017 Feb 03.
Autor:
Ledoux G; CHU Lille, Centre de Réanimation, Lille, France., Six S; CHU Lille, Centre de Réanimation, Lille, France., Lawson R; CHU Lille, Centre de Réanimation, Lille, France., Labreuche J; CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, Lille, France., Blazejewski C; CH de Dunkerque, Service de réanimation polyvalente, Dunkerque, France., Wallet F; CHU Lille, Centre de Biologie et de Pathologie, Lille, France., Duhamel A; CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, Lille, France; Université Lille, Medical School, Lille, France., Nseir S; CHU Lille, Centre de Réanimation, Lille, France; Université Lille, Medical School, Lille, France. Electronic address: s-nseir@chru-lille.fr.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2016 Oct; Vol. 22 (10), pp. 888.e11-888.e18. Date of Electronic Publication: 2016 Jul 21.
Autor:
Cecchetto S, Lawson R
Publikováno v:
Perception [Perception] 2015; Vol. 44 (7), pp. 743-54.